|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Analytical & Consulting Chemists in UK |
|
|
|
|
€ 525,00 |
Editeur
: |
Plimsoll Publishing Ltd |
Langue
: |
Anglais |
Date de publication : |
Février 2008 |
Taille du document : |
180 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
The Pharmaceutical industry in the 21st Century
150 pages | Octobre 1998 |
Does the 21st century herald the beginning of a genomics revolution? Which disease areas will provide the greatest growth potential and why? Which technologies have the greatest potential to max |
795,00 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Patient Power Outlook 2001
152 pages | Juillet 2001 |
The increase in patient power witnessed over the last decade has been driven by developments in healthcare systems, patient advocacy activity, the increasing influence of the media in healthcare issue |
955,00 €
|
| |
| |
The Pharmaceutical Profitability Outlook
150 pages | Février 1999 |
Is pharmaceutical profitability sustainable into the 21st century? “As the pharmaceutical industry finds itself at a crossroads, the strategic directions companies take will be pivotal in determini |
795,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis
150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
The Drug Delivery Outlook 2001
176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery.
Subseque |
955,00 €
|
| |
| |
Lifestyle Drugs Outlook to 2005
130 pages | Février 1999 |
Definition of lifestyle drugs : The disease, product and social characteristics that make a drug lifestyle drug.
Epidemiology : The patient potential for lifestyle drugs such as sexual dysfuncti |
795,00 €
|
| |
| |
The Diagnostics Outlook to 2005
130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
795,00 €
|
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Analytical & Consulting Chemists in UK |
|
|
The Plimsoll Portfolio Analysis - Analytical & Consulting Chemists is a comprehensive evaluation of the UK market. The revised and updated 2008 edition analyses the financial performance of the companies important to the success of your business. Using the most up to date information available, the analysis is ideal both as a tool to benchmark your own company's results and to study the market in more depth. Aimed at the busy manager, the Plimsoll Portfolio Analysis is both quick and easy to use thanks to the unique visual layout. The Analysis lays bare the performance of each company highlighting their strengths and weaknesses. Do you know which companies are best to do business with? Do you know which companies are selling at a loss and whose profit margins are plummeting? Find out the answers to all these questions and more with the newly published Plimsoll Portfolio Analysis.
The report is divided into two colour-coded sections for your ease of use, Sector Analysis and Individual Company Analysis. Sector Analysis: Sales growth, market share and profitability are all analysed over a 10 year period giving you the fulllest picture possible of the health of the market. Companies are ranked on these categories so you can see which companies are outshining the rest. Use the industry average tables to benchmark your own company's performance- how do you compare to the rest of the industry? Industry Analysis: Each company receives a full page of analysis, evaluating their financial performance over the last five years so you get a full picture of the long term prospects of each company. Each company page of analysis is also packed with the following information: Full business name and address, Names and ages of directors, contact details and website address, seven unique 'Plimsoll' charts showing at a glance the performance of each company, averages for the industry are also shown indicating the bare minimum each company should be looking to achieve, and five years of the latest accounts available, New! Written summary on each company highlighting their key strengths and weaknesses.
The Analysis evaluates the performance of 100 companies.
|
|
|
PPLSEN
|
|
|
|
|
